Literature DB >> 25200062

Midodrine efficacy in orthostatic hypotension.

W Singer1, M J Joyner, P Sandroni, E E Benarroch, R D Fealey, J Mandrekar, P A Low.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25200062      PMCID： PMC4238194          DOI： 10.1007/s11606-014-3014-7

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   5.128


× No keyword cloud information.
  7 in total

1.  Preliminary observations on the use of midodrine in treating orthostatic hypotension in familial dysautonomia.

Authors:  F B Axelrod; L Krey; J S Glickstein; J W Allison; D Friedman
Journal:  J Auton Nerv Syst       Date:  1995-10-05

2.  Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension. A randomized, double-blind multicenter study. Midodrine Study Group.

Authors:  P A Low; J L Gilden; R Freeman; K N Sheng; M A McElligott
Journal:  JAMA       Date:  1997-04-02       Impact factor: 56.272

3.  Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine.

Authors:  J Jankovic; J L Gilden; B C Hiner; H Kaufmann; D C Brown; C H Coghlan; M Rubin; F M Fouad-Tarazi
Journal:  Am J Med       Date:  1993-07       Impact factor: 4.965

4.  Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension.

Authors:  F M Fouad-Tarazi; M Okabe; H Goren
Journal:  Am J Med       Date:  1995-12       Impact factor: 4.965

5.  Effects of midodrine on exercise-induced hypotension and blood pressure recovery in autonomic failure.

Authors:  William G Schrage; John H Eisenach; Frank A Dinenno; Shelly K Roberts; Christopher P Johnson; Paola Sandroni; Philip A Low; Michael J Joyner
Journal:  J Appl Physiol (1985)       Date:  2004-07-23

6.  A double-blind, dose-response study of midodrine in neurogenic orthostatic hypotension.

Authors:  R A Wright; H C Kaufmann; R Perera; T L Opfer-Gehrking; M A McElligott; K N Sheng; P A Low
Journal:  Neurology       Date:  1998-07       Impact factor: 9.910

Review 7.  Midodrine. A review of its pharmacological properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders.

Authors:  D McTavish; K L Goa
Journal:  Drugs       Date:  1989-11       Impact factor: 9.546
  7 in total
  4 in total

Review 1.  Management of Hypertension and Blood Pressure Dysregulation in Patients with Parkinson's Disease-a Systematic Review.

Authors:  Vasiliki Katsi; Ilias Papakonstantinou; Eirini Solomou; Alexios S Antonopoulos; Charalambos Vlachopoulos; Konstantinos Tsioufis
Journal:  Curr Hypertens Rep       Date:  2021-05-07       Impact factor: 5.369

Review 2.  Pathophysiology and Treatment of Orthostatic Hypotension in Parkinsonian Disorders.

Authors:  Dong In Sinn; Christopher H Gibbons
Journal:  Curr Treat Options Neurol       Date:  2016-06       Impact factor: 3.598

3.  A new use for old drugs: identifying compounds with an anti-obesity effect using a high through-put semi-automated Caenorhabditis elegans screening platform.

Authors:  Freek Haerkens; Charlotte Kikken; Laurens Kirkels; Monique van Amstel; Willemijn Wouters; Els van Doornmalen; Christof Francke; Samantha Hughes
Journal:  Heliyon       Date:  2022-08-11

4.  Stimulation of Alpha1-Adrenergic Receptor Ameliorates Cellular Functions of Multiorgans beyond Vasomotion through PPARδ.

Authors:  Yong-Jik Lee; Hyun Soo Kim; Hong Seog Seo; Jin Oh Na; You-Na Jang; Yoon-Mi Han; Hyun-Min Kim
Journal:  PPAR Res       Date:  2020-02-01       Impact factor: 4.964
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.